Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures

Ferring Pharmaceuticals23 enrolled

Overview

In this non-interventional multicentre, prospective, observational cohort study, the efficacy of desmopressin is evaluated in patients with platelet dysfunction due to acetylsalicylic acid or cox-1-inhibitors within the context of surgical procedures.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Platelet Dysfunction

Interventions

desmopressinDRUG

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Pre-, peri- or postoperative treatment with a standard dose of desmopressin as a result of platelet dysfunction (disturbance of blood platelet function) due to treatment with acetylsalicylic acid or cox-1-inhibitor. * Decision on the therapy with MINIRIN parenteral 4 Microgram/ml solution for injection has already been made independently by the physician beforehand * The patients (≥ 18 years) have been informed about the non-interventional study and have given their written consent for participation Exclusion Criteria: * Participation in a clinical trial * Treatment with acetylsalicylic acid for cardiovascular indications

Locations (1)

Charité - Universitätsmedizin Berlin (there may be other sites in this country)

Berlin, Germany

Outcomes

Primary Outcomes

Change in platelet function pre- and post-administration of desmopressin

As measured by Platelet Function Analyzer (PFA) 100/200

Time frame: From baseline up to 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.